Report

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Expert Market Research Thumbnail Image

Global Companion Diagnostics Market: By Product & Service: Assay Kits and Reagents, Software and Services; By Technology: Polymerase Chain Reaction, Immunohistochemistry, In Situ Hybridization, Next-Generation Sequencing, Other Technologies; By Indication: Oncology, Neurology; By End Use: Pharmaceutical and Biopharmaceutical Companies, Reference Laboratories, Other End Users; By Region: North America, Europe, Asia Pacific, Latin America, Middle East & Africa; Historical Production and Consumption (2015-2019); Production and Consumption Forecast (2020-2025); SWOT Analysis: Porter’s Five Forces Analysis: Competitive Landscape & Supplier Analysis : Events and Developments

Global Companion Diagnostics Market Key Insights:

 

  • Market Overview
  • Market Opportunities
  • Breakup by Regions
  • Historical Market Size 2015-2019
  • Competitive Landscape
  • SWOT Analysis
  • Market Forecast 2020-2025
  • Events and Developments
  • Market Indicators

 

Market Outlook

The global companion diagnostics market size stood at a value of USD 2.1 billion in 2019. The companion diagnostics market is expected to achieve USD 8.4 billion by 2025, growing at a CAGR of 26% between the forecast period of 2020 and 2025. The companion diagnostics industry is anticipated to grow significantly during the forecast period due to an increase in R&D of targeted therapies for cancer, along with the increasing demand for personalised medicine.

https://www.expertmarketresearch.com/files/images/Global-Companion-Diagnostics-Market-Report-and-Forecast-2020-2025.png

Get a Free Sample Report with Table of Content - Download Now

Properties and Applications

A companion diagnostic is a medical in-vitro device that offers data for the secure and efficient use of a drug and determines its applicability to a specific person. This diagnostic test enables a medical specialist to determine whether a specific therapeutic product helps patients or not, outweighing any severe potential side effects or hazards. The industry can be divided based on its product and services into assay kits and reagents, and software and services.

The industry can be broadly categorised based on its end-use into:

  • Pharmaceutical and Biopharmaceutical Companies 
  • Reference Laboratories 
  • Other

The industry can be divided based on its technology as polymerase chain reaction, immunohistochemistry, in situ hybridization, and next-generation sequencing, among others.

The industry can be divided based on indication as:

  • Oncology 
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Melanoma
  • Gastric Cancer
  • Other Cancers
  • Neurology 
  • Infectious Diseases 
  • Other Indications

The EMR report looks into the regional companion diagnostics markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

Market Analysis

The increased popularity of personalised medicines, rising cases of adverse drug reactions (ADRs) and higher number of unmet needs for treating cancer are the driving factors, accelerating the growth of the companion diagnostics market. An increase in healthcare expenditure, globally, and technological advancements in diagnostic techniques are propelling the positive growth of the industry. With rising awareness, particularly in developing economies, along with the discovery of new biomarkers for diverse conditions, the industry is witnessing a further growth. The growth of the companion animal diagnostics market will also propel the growth of the overall companion diagnostics industry. The cases of cancer is expected drive the growth of the companion diagnostics industry in the oncology segment. The approval of companion diagnostics by government agencies like the FDA is expected to drive the growth of the industry. Unfavourable reimbursement policies in some countries may affect the companion diagnostics market growth during the forecast period.

Competitive Landscape

The report presents a detailed analysis of the following leading companies in the global companion diagnostics market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • F. Hoffmann-La Roche AG
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc. 
  • Abbott Laboratories, Inc. 
  • Biomérieux SA 
  • Danaher Corporation
  • Illumina, Inc.
  • Myriad Genetics, Inc
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Questions Answered in the Global Companion Diagnostics Market Report:

  • How has the global companion diagnostics market performed in the previous years (2015-2019)?
  • What is the forecast assessment of the industry for 2020-2025?
  • What are the major drivers for the historical (2015-2019) and forecast (2020-2025) periods?
  • What are the major constraints for the historical (2015-2019) and forecast (2020-2025) periods?
  • What are the major demand indicators of the global industry?
  • Who are the key manufacturers in the global companion diagnostics market?
  • What is the degree of competition in the global industry?
  • What are the major events and developments taking place within the industry globally?

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Cost Structure
    4.5    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6    Global Companion Diagnostics Market Analysis
    6.1    Global Companion Diagnostics Market (2015-2019) & Forecast (2020-2025)
    6.2    Global Companion Diagnostics Market Breakup by Product & Service
        6.2.1    Assay Kits and Reagents 
        6.2.2    Software and Services 
    6.3    Global Companion Diagnostics Market Breakup by Product & Service: Historical Market (2015-2019) & Forecast (2020-2025)
        6.3.1    Assay Kits and Reagents 
        6.3.2    Software and Services 
    6.4    Global Companion Diagnostics Market by Technology
        6.4.1    Polymerase Chain Reaction 
        6.4.2    Immunohistochemistry 
        6.4.3    In Situ Hybridization 
        6.4.4    Next-Generation Sequencing 
        6.4.5    Other Technologies 
    6.5    Global Companion Diagnostics Market by Technology: Historical Market (2015-2019) & Forecast (2020-2025)
        6.5.1    Polymerase Chain Reaction 
        6.5.2    Immunohistochemistry 
        6.5.3    In Situ Hybridization 
        6.5.4    Next-Generation Sequencing 
        6.5.5    Other Technologies 
    6.6    Global Companion Diagnostics Market by Indication
        6.6.1    Oncology 
            6.6.1.1    Breast Cancer
            6.6.1.2    Lung Cancer
            6.6.1.3    Colorectal Cancer
            6.6.1.4    Melanoma
            6.6.1.5    Gastric Cancer
            6.6.1.6    Other Cancers
        6.6.2    Neurology 
            6.6.2.1    Infectious Diseases 
            6.6.2.2    Other Indications
    6.7    Global Companion Diagnostics Market by Indication: Historical Market (2015-2019) & Forecast (2020-2025)
        6.7.1    Oncology 
            6.7.1.1    Breast Cancer
            6.7.1.2    Lung Cancer
            6.7.1.3    Colorectal Cancer
            6.7.1.4    Melanoma
            6.7.1.5    Gastric Cancer
            6.7.1.6    Other Cancers
        6.7.2    Neurology 
            6.7.2.1    Infectious Diseases 
            6.7.2.2    Other Indications
    6.8    Global Companion Diagnostics Market by End Use 
        6.8.1    Pharmaceutical and Biopharmaceutical Companies 
        6.8.2    Reference Laboratories 
        6.8.3    Other End Users
    6.9    Global Companion Diagnostics Market by End Use: Historical Market (2015-2019) & Forecast (2020-2025)
        6.9.1    Pharmaceutical and Biopharmaceutical Companies 
        6.9.2    Reference Laboratories 
        6.9.3    Other End Users
    6.10    Global Companion Diagnostics Market Breakup by Region
        6.10.1    North America
            6.10.1.1    United States of America
            6.10.1.2    Canada
        6.10.2    Europe
            6.10.2.1    Germany
            6.10.2.2    United Kingdom
            6.10.2.3    France
            6.10.2.4    Italy
            6.10.2.5    Others
        6.10.3    Asia Pacific
            6.10.3.1    China
            6.10.3.2    Japan
            6.10.3.3    India
            6.10.3.4    ASEAN
            6.10.3.5    Others
        6.10.4    Latin America
            6.10.4.1    Brazil
            6.10.4.2    Argentina
            6.10.4.3    Mexico
            6.10.4.4   Others
        6.10.5    Middle East & Africa
            6.10.5.1    Saudi Arabia
            6.10.5.2    United Arab Emirates
            6.10.5.3    Nigeria
            6.10.5.4    South Africa
            6.10.5.5    Others
    6.11     Global Companion Diagnostics Market Breakup by Region: Historical Market (2015-2019) & Forecast (2020-2025)
        6.11.1    North America
            6.11.1.1    United States of America
            6.11.1.2    Canada
        6.11.2    Europe
            6.11.2.1    Germany
            6.11.2.2    United Kingdom
            6.11.2.3    France
            6.11.2.4    Italy
            6.11.2.5    Others
        6.11.3    Asia Pacific
            6.11.3.1    China
            6.11.3.2    Japan
            6.11.3.3    India
            6.11.3.4    ASEAN
            6.11.3.5    Others
        6.11.4    Latin America
            6.11.4.1    Brazil
            6.11.4.2    Argentina
            6.11.4.3    Mexico
            6.11.4.4   Others
        6.11.5    Middle East & Africa
            6.11.5.1    Saudi Arabia
            6.11.5.2    United Arab Emirates
            6.11.5.3    Nigeria
            6.11.5.4    South Africa
            6.11.5.5    Others
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis 
    9.1    F. Hoffmann-La Roche AG 
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    Agilent Technologies, Inc. 
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    Qiagen N.V. 
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    Thermo Fisher Scientific Inc. 
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    Abbott Laboratories, Inc. 
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Biomérieux SA 
        9.6.1    Company Overview
        9.6.2    Financial Analysis
    9.7    Danaher Corporation 
        9.7.1    Company Overview
        9.7.2    Financial Analysis
    9.8    Illumina, Inc. 
        9.8.1     Company Overview
        9.8.2    Financial Analysis
    9.9    Myriad Genetics, Inc
        9.9.1    Company Overview
        9.9.2    Financial Analysis
    9.10    Others
10    Events and Developments

Introduction

EMR is one of the foremost business intelligence and market research companies with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.

Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each industry and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with industry insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:

  • Value-added and infallible market intelligence.
  • A holistic understanding of the current and expected market fluctuations through meticulously collected data.
  • Verified information on the probable opportunities and risks in the present and forecasted markets.
  • Validated and thoroughly analysed insights derived from our latest analytical tools and impeccable sources.

Assessment Approach

Our approach gives our clients a comprehensive assessment of the prevailing and projected industry conditions through the collection, collation, and analysis of data from trusted sources.

Price Assessment

We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable industry strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.

Market Assessment

Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.

Data Collection

We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the industry.

Primary Research

As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.

Secondary Research

EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing industry conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the industry, the supply chain, the competitive landscape, and the product.

Other Analyst Tools and Data Models

Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and industry strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.

Data Prioritisation

Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.

Data Validation

Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.

Exigent Data Assessment

Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the industry, our market and price assessments accurately reflect the prevailing industry conditions.

Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.

Purchase Options  

Buy Now  

Call us on

( USA & Canada )
+1-415-325-5166
us.sales@expertmarket
research.com
( United Kingdom )
+44-702-402-5790
uk.sales@expertmarket
research.com
Send Enquiry  

Purchase Full Report

  • Single User License
  • $2999
  • Restricted to one user
  • One print only
  • Available in PDF
  • Free limited customisation (pre sales)
  • Post sales analyst support
  • Free report update (Within 180 Days)
  • Buy Now
  • Five User License
  • $3999
  • Restricted to five users
  • One print per user
  • Available in PDF
  • Free limited customisation (pre sales)
  • Post sales analyst support
  • Free report update (Within 180 Days)
  • Buy Now
  • Corporate License
  • $4999
  • Unlimited users within organisation
  • No limit on prints
  • Available in PPT and PDF
  • Free limited customisation (pre sales)
  • Post sales analyst support
  • Free report update (Within 180 Days)
  • Buy Now

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Expert Market Research Thumbnail Image
Global Veterinary Infectious Disease Diagnostics Market Report and Forecast 2020-2025

The global veterinary infectious disease diagnostics market stood at a value of nearly USD 1.5 billion in 2019. The industry is further expected to grow at a CAGR of almost 8.8% in the forecast period...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Vitamin D Testing Market Report and Forecast 2020-2025

Vitamin D deficiency has now become a common problem affecting many people worldwide, especially older adults. As vitamin D plays a key role in bone development as well as calcification, many people a...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Shoulder Replacement Market Report and Forecast 2020-2025

The global shoulder replacement market is projected to attain a value of USD 3 billion by the end of 2025, growing in the forecast period of 2020-2025 at a CAGR of 7.5%. The shoulder replacement marke...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Influenza Diagnostics Market Report and Forecast 2020-2025

The global influenza diagnostics market attained a value of USD 657 million in 2019. The influenza diagnostics market is further expected to grow in the forecast period of 2020-2025 at a CAGR of 9% to...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Bacterial Disease Diagnostics Market Report and Forecast 2020-2025

The market is significantly being supported by the integration of digital health technology in bacterial disease rapid diagnostics. North America is among the most significant regions for the market. ...

  • 24 Hour Email Delivery
  • Price: $ 2999

Stay informed with our free industry updates.

Download Sample

Buy Full Version
"Companion Diagnostics Market" Purchase Enquiry